<
https://ann-clinmicrob.biomedcentral.com/articles/10.1186/s12941-025-00793-9>
"Long COVID is a complex, heterogeneous syndrome affecting over four hundred
million people globally. There are few recommendations, and no formal training
exists for medical professionals to assist with clinical evaluation and
management of patients with Long COVID. More research into the pathology,
cellular, and molecular mechanisms of Long COVID, and treatments is needed. The
goal of this work is to disseminate essential information about Long COVID and
recommendations about definition, diagnosis, treatment, research and social
issues to physicians, researchers, and policy makers to address this escalating
global health crisis."
Via Violet Blue’s
Threat Model - Covid: April 24, 2025
https://www.patreon.com/posts/covid-april-24-127332605
Cheers,
*** Xanni ***
--
mailto:xanni@xanadu.net Andrew Pam
http://xanadu.com.au/ Chief Scientist, Xanadu
https://glasswings.com.au/ Partner, Glass Wings
https://sericyb.com.au/ Manager, Serious Cybernetics
